Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Precision Nanomedicine|October 22, 2021
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication <i>in vitro</i>Guankui Wang, Hanmant Gaikwad, Mary K McCarthy, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2022
Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumorsIrina V Balyasnikova, Markella Zannikou, Guankui Wang, et al.ACS Nano|October 19, 2017
Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital MicroscopyJames I Griffin, Guankui Wang, Weston J Smith, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 5, 2021
Complement opsonization of nanoparticles: Differences between humans and preclinical speciesYue Li, Guankui Wang, Lynn Griffin, et al.Particle and Fibre Toxicology|November 27, 2014
Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serumNirmal K Banda, Gaurav Mehta, Ying Chao, et al.Nature Nanotechnology|January 16, 2019
Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticlesVivian P Vu, Geoffrey B Gifford, Fangfang Chen, et al.Nature Nanotechnology|October 5, 2023
Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteinsYue Li, Sarah Jacques, Hanmant Gaikwad, et al.Nature Nanotechnology|January 24, 2019
Publisher Correction: Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticlesVivian P Vu, Geoffrey B Gifford, Fangfang Chen, et al.Nature Nanotechnology|December 20, 2016
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivoFangfang Chen, Guankui Wang, James I Griffin, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 12, 2019
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55Geoffrey Gifford, Vivian P Vu, Nirmal K Banda, et al.Pageof 4